CST-2032

· CuraSen Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CST-2032, covering 2025-01-23 to 2025-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease [Phase 2]

See pricing